Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both

Edith A. Perez, David W. Hillman, James A. Mailliard, James N. Ingle, J. Michael Ryan, Tom R. Fitch, Kendrith M. Rowland, Carl G. Kardinal, James E. Krook, John W. Kugler, Shaker R. Dakhil

Research output: Contribution to journal › Article › peer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both'. Together they form a unique fingerprint.

Medicine & Life Sciences